Cancer Moonshot Initiatives

Abstract

DoD Cancer Moonshot 2 (CM2) is a mission assigned by the DoD to USU’s Murtha Cancer Center Research Program (MCCRP) as a mandate from the White House’s federal cancer moonshot part 2 that was initiated in 2022. CM2 is the next generation of the original federal cancer moonshot program initiated in 2016, for which the MCCRP is actively engaged in ongoing cancer studies. The DoD CM2 program will build on DoD’s original Moonshot areas of study by enhancing the MCCRP’s current initiatives and further utilizing and leveraging DoD’s unique and additional capabilities to contribute to advancement of the cancer prevention, diagnosis and treatment goals of CM2. The MCCRP’s three new initiatives under the CM2 for DoD include: 1) Cancer Research and Clinical Trial Network; 2) Epidemiology; and 3) DoD Serum Repository Projects.

Open PDF

Document Details

Document Type
Project
Publication Date
Oct 01, 2023
Source ID
511_0603115DHA_2_0130_PB_2023

Tags

Readers

  • Defense Acquisition Program Management
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.

Related Documents